4.7 Review

Is salivary gland ultrasonography a useful tool in Sjogren's syndrome? A systematic review

Journal

RHEUMATOLOGY
Volume 55, Issue 5, Pages 789-800

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/kev385

Keywords

ultrasonography; salivary gland; reproducibility; validity; reliability; primary Sjogren's syndrome

Categories

Ask authors/readers for more resources

Objective. Ultrasonography (US) is a sensitive tool in the diagnosis of major salivary gland abnormalities in primary Sjogren's syndrome (pSS). The aim of this systematic review was to assess the metric properties of this technique. Methods. PUBMED and EMBASE databases were searched. All publications between January 1988 and January 2013 were considered. Data were extracted from the articles meeting the inclusion criteria according to US definition of salivary gland scoring system and metric properties studied. The type and number of glands tested, study design and metric properties according to OMERACT filter (truth, discrimination, feasibility) were assessed. Results. Of 167 publications identified initially with PUBMED and EMBASE, 31 met the inclusion criteria. The number of pSS patients varied among the studies from 16 to 140. The diagnosis of pSS was in line in most of the cases with the American-European Consensus Group (AECG) classification criteria for Sjogren's syndrome. The US examination was performed in suspected pSS only in studies in which the sensitivity ranged from 45.8 to 91.6% and specificity from 73 to 98.1%. There was heterogeneity in regard to the definition of US in B-mode and few studies used US in colour Doppler. Few studies reported reliability of US and sensitivity to change in pSS. Conclusion. US is a valuable tool for detecting salivary gland abnormalities in pSS. Its reliability has been poorly investigated and there is considerable variation in the definition of US abnormalities. Further studies are required to validate and standardize the US definition of salivary gland in pSS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Rheumatology

Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'

Aimilios Kaklamanos, Panagiotis Karamichalos, Panayiotis G. Vlachoyiannopoulos, Athanasios G. Tzioufas

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Biochemistry & Molecular Biology

Addressing the clinical unmet needs in primary Sjogren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts

Vasileios C. Pezoulas, Andreas Goules, Fanis Kalatzis, Luke Chatzis, Konstantina D. Kourou, Aliki Venetsanopoulou, Themis P. Exarchos, Saviana Gandolfo, Konstantinos Votis, Evi Zampeli, Jan Burmeister, Thorsten May, Manuel Marcelino Perez, Iryna Lishchuk, Thymios Chondrogiannis, Vassiliki Andronikou, Theodora Varvarigou, Nenad Filipovic, Manolis Tsiknakis, Chiara Baldini, Michele Bombardieri, Hendrika Bootsma, Simon J. Bowman, Muhammad Shahnawaz Soyfoo, Dorian Parisis, Christine Delporte, Valerie Devauchelle-Pensec, Jacques-Olivier Pers, Thomas Doerner, Elena Bartoloni, Roberto Gerli, Roberto Giacomelli, Roland Jonsson, Wan-Fai Ng, Roberta Priori, Manuel Ramos-Casals, Kathy Sivils, Fotini Skopouli, Witte Torsten, Joel A. G. van Roon, Mariette Xavier, Salvatore De Vita, Athanasios G. Tzioufas, Dimitrios Fotiadis

Summary: This article presents the HarmonicSS cloud computing exemplar platform, which provides state-of-the-art data analytics services to address the clinical unmet needs of primary Sjogren's Syndrome (pSS). The platform successfully develops lymphoma classification models and identifies biomarkers for lymphomagenesis by interlinking, curating, and harmonizing multiple regional and international databases. The federated AI algorithms trained on the harmonized databases yield robust lymphoma classification models with high accuracy and identify 5 biomarkers for lymphoma development.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)

Article Endocrinology & Metabolism

Hashimoto Thyroiditis, Anti-Parietal Cell Antibodies: Associations With Autoimmune Diseases and Malignancies

Georgios Boutzios, Eleni Koukoulioti, Andreas V. Goules, Ioannis Kalliakmanis, Ilias Giovannopoulos, Panayiotis Vlachoyiannopoulos, Haralampos M. Moutsopoulos, Athanasios G. Tzioufas

Summary: This study reveals an association of APCA with organ-specific autoimmunity in HT patients for the first time. APCA and patient age were independently associated with the presence of organ-specific autoimmunity. Additionally, this study showed an association between APCA and gastric neoplasms in these patients.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Immunology

COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases

Athanasios-Dimitrios Bakasis, Clio P. Mavragani, Paraskevi V. Voulgari, Nafsika Gerolymatou, Ourania D. Argyropoulou, Panayiotis G. Vlachoyiannopoulos, Fotini N. Skopouli, Athanasios G. Tzioufas, Haralampos M. Moutsopoulos

Summary: This observational study reports the clinical features and outcomes of COVID-19 in patients with systemic autoimmune and autoinflammatory rheumatic diseases (SAARD) who were unvaccinated or received 2 or 3 doses of the SARS-CoV-2 vaccine. The study found that vaccination with 2 or 3 doses significantly reduced hospitalizations and the need for oxygen supplementation in COVID-19 patients with SAARD. Furthermore, the study showed that receiving 3 doses of the vaccine was associated with a significantly lower risk of severe/critical COVID-19.

JOURNAL OF AUTOIMMUNITY (2022)

Review Rheumatology

Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)

Luca Quartuccio, Alessandra Bortoluzzi, Carlo Alberto Scire, Antonio Marangoni, Giulia Del Frate, Elena Treppo, Laura Castelnovo, Francesco Saccardo, Roberta Zani, Marco Candela, Paolo Fraticelli, Cesare Mazzaro, Piero Renoldi, Patrizia Scaini, Davide Antonio Filippini, Marcella Visentini, Salvatore Scarpato, Dilia Giuggioli, Maria Teresa Mascia, Marco Sebastiani, Anna Linda Zignego, Gianfranco Lauletta, Massimo Fiorilli, Milvia Casato, Clodoveo Ferri, Maurizio Pietrogrande, Pietro Enrico Pioltelli, Salvatore De Vita, Giuseppe Monti, Massimo Galli

Summary: Cryoglobulinemic vasculitis is a small-vessel vasculitis characterized by the proliferation of B-cell clones producing pathogenic immune complexes. It is often secondary to hepatitis C virus, autoimmune diseases, and hematological malignancies. The clinical course of cryoglobulinemic vasculitis is usually mild, but severe organ damage and life-threatening manifestations can occur.

CLINICAL RHEUMATOLOGY (2023)

Correction Rheumatology

Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) (Sept, 10.1007/s10067-022-06391-w, 2022)

Luca Quartuccio, Alessandra Bortoluzzi, Carlo Alberto Scire, Antonio Marangoni, Giulia Del Frate, Elena Treppo, Laura Castelnovo, Francesco Saccardo, Roberta Zani, Marco Candela, Paolo Fraticelli, Cesare Mazzaro, Piero Renoldi, Patrizia Scaini, Davide Antonio Filippini, Marcella Visentini, Salvatore Scarpato, Dilia Giuggioli, Maria Teresa Mascia, Marco Sebastiani, Anna Linda Zignego, Gianfranco Lauletta, Massimo Fiorilli, Milvia Casato, Clodoveo Ferri, Maurizio Pietrogrande, Pietro Enrico Pioltelli, Salvatore De Vita, Giuseppe Monti, Massimo Galli

CLINICAL RHEUMATOLOGY (2023)

Editorial Material Rheumatology

The pre-clinical phase of giant cell arteritis: new clues in the pathogenesis of giant cell arteritis supporting emerging targets

Luca Quartuccio, Elena Treppo, Christian Dejaco

RHEUMATOLOGY (2023)

Article Medicine, General & Internal

Humoral and T-Cell Mediated Response after the Third Dose of mRNA Vaccines in Patients with Systemic Lupus Erythematosus on Belimumab

Luca Quartuccio, Ginevra De Marchi, Rossana Domenis, Nicola Cabas, Silvia Guella, Antonella Paradiso, Cinzia Fabro, Antonio Paolo Beltrami, Salvatore De Vita, Francesco Curcio

Summary: This study evaluated the humoral and cellular immune response in systemic lupus erythematosus (SLE) patients treated with Belimumab after receiving three doses of SARS-CoV-2 mRNA vaccines. The results showed that all patients had a humoral response after the first dose, but the antibody titer significantly declined after the second dose. However, the third dose led to a significant increase in antibody titer, restoring it to the level before vaccination. The cellular-mediated response declined after the second dose but did not further decline after the third dose. There were no significant differences in humoral and cellular responses between patients and controls.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Immunology

COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity

Laura Gragnani, Marcella Visentini, Serena Lorini, Stefano Angelo Santini, Gianfranco Lauletta, Cesare Mazzaro, Teresa Urraro, Luca Quartuccio, Fabio Cacciapaglia, Piero Ruscitti, Antonio Tavoni, Silvia Marri, Giuseppina Cusano, Luisa Petraccia, Caterina Naclerio, Elena Treppo, Giulia del Frate, Ilenia Di Cola, Vincenzo Raimondo, Daniela Scorpiniti, Monica Monti, Lorenzo Puccetti, Giusy Elia, Poupak Fallahi, Stefania Basili, Salvatore Scarpato, Florenzo Iannone, Milvia Casato, Alessandro Antonelli, Anna Linda Zignego, Clodoveo Ferri

Summary: This study investigated the prevalence and outcome of COVID-19 in a large series of MCs patients, as well as the safety and immunogenicity of COVID-19 vaccines. The results showed a significantly higher prevalence of COVID-19 in MCs patients compared to the general population, and the use of immunomodulators was associated with an increased risk of infection. Additionally, MCs patients with COVID-19 had a higher mortality rate, and older age was correlated with worse COVID-19 outcomes. The vaccination immunogenicity was impaired in MCs patients, and certain immunomodulators hindered the vaccine-induced immune response.

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Editorial Material Rheumatology

The paradigm shift in ANCA-associated vasculitis: prime time for the complement targeting

Luca Quartuccio, Elena Treppo, Federico Alberici

RHEUMATOLOGY (2023)

Article Integrative & Complementary Medicine

Can Electroacupuncture Be Useful in Opioid-Induced Hyperalgesia? A Case Report

Marco Di Carlo, Antonio D'Addario, Fausto Salaffi

Summary: Electroacupuncture has demonstrated clinical efficacy in treating opioid-induced hyperalgesia (OIH) and could be a potential treatment option for complex and difficult-to-manage conditions such as OIH.

JOURNAL OF ACUPUNCTURE AND MERIDIAN STUDIES (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Quantification of sarcopenia in patients with rheumatoid arthritis by measuring the cross-sectional area of the thigh muscles with magnetic resonance imaging

Fausto Salaffi, Marina Carotti, Anna Claudia Poliseno, Luca Ceccarelli, Sonia Farah, Marco Di Carlo, Andrea Giovagnoni

Summary: This study aimed to determine the utility of CSA measurements on MRI, at the level of the thigh muscles, in discriminating RA patients with sarcopenia. The results showed that MRI-CSA-25 can differentiate RA patients with sarcopenia from those without.

RADIOLOGIA MEDICA (2023)

Article Allergy

Inflammaging and Frailty in Immune-Mediated Rheumatic Diseases: How to Address and Score the Issue

Fausto Salaffi, Andrea Di Matteo, Sonia Farah, Marco Di Carlo

Summary: Frailty is a new concept in rheumatology that can help identify individuals with a higher risk of negative outcomes. It is linked to aging and an increased risk of falls, injuries, and mortality. Inflammation affects immune pathways, multimorbidity, and frailty. Frailty is more common as people age in the community, and various parameters have been validated to identify it.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2023)

Meeting Abstract Rheumatology

CD20+T Cells in the Synovial Fluid of Patients with Rheumatoid Arthritis Suggest a Role for Trogocytosis in Disease Pathogenesis and Activity

Maria De Santis, Natasa Isailovic, Giacomo Maria Guidelli, Daniela Renna, Arianna Sonaglia, Nicoletta Luciano, Marta Caprioli, Angela Ceribelli, Francesca Motta, Matteo Vecellio, Enrico Brunetta, Carlo Selmi

ARTHRITIS & RHEUMATOLOGY (2022)

Meeting Abstract Rheumatology

Depression and Other Neurological Disorders Are Associated with Biologic DMARD Failure in Psoriatic Arthritis

Nicoletta Luciano, Elisa Barone, Enrico Brunetta, Maria De Santis, Angela Ceribelli, Marta Caprioli, Giacomo Maria Guidelli, Arianna Sonaglia, Daniela Renna, Francesca Motta, Natasa Isailovic, Matteo Vecellio, Carlo Selmi

ARTHRITIS & RHEUMATOLOGY (2022)

No Data Available